Biomagnetics Diagnostics Corp. engages in the provision of medical and biotechnology devices. The company is headquartered in Orangevale, California. The company went IPO on 2002-04-09. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test. The firm triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
根據最新的財務報表(Form-10K),Charoen Pokphand Foods Public Company Limited 的總資產為 $861,796,淨isProfitable}為 $24,116
BMGP 的關鍵財務比率是什麼?
Charoen Pokphand Foods Public Company Limited 的流動比率為 1.37,淨利潤率為 4.22,每股銷售為 $73.98。
Biomagnetics Diagnostics Corp 的收入按細分市場或地理位置如何劃分?
Charoen Pokphand Foods Public Company Limited 最大收入來源為 Livestock,在最近的收益報告中收入為 514,448,000,000。就地區而言,Asia 是 Charoen Pokphand Foods Public Company Limited 的主要市場,收入為 286,169,000,000。
Biomagnetics Diagnostics Corp 是否盈利?
是的,根據最新的財務報表,Charoen Pokphand Foods Public Company Limited 的淨利潤為 $24,116
Biomagnetics Diagnostics Corp 有負債嗎?
是的,Charoen Pokphand Foods Public Company Limited 的負債為 629,044
Biomagnetics Diagnostics Corp 的流通股有多少?
Charoen Pokphand Foods Public Company Limited 的總流通股為 7,637.96